PTC Therapeutics (PTCT) CBO sells shares under 10b5-1 trading plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PTC Therapeutics chief business officer Eric Pauwels exercised stock options and sold shares in pre-planned trades. On June 10, 2026, he exercised options to acquire 17,566 shares of Common Stock at $18.01 per share, then executed open-market sales totaling 21,277 shares at $75.00 per share. Following these transactions, he held 73,411 shares of Common Stock directly. The trades were carried out under a written Rule 10b5-1 plan adopted on February 25, 2026, indicating they were pre-scheduled rather than timed discretionarily.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 38,843 shares ($1,595,775)
Net Sell
4 txns
Insider
Pauwels Eric
Role
CHIEF BUSINESS OFFICER
Sold
38,843 shs ($1.60M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Stock Option (Right to Buy) | 17,566 | $0.00 | -- |
| Sale | Common Stock | 3,711 | $75.00 | $278K |
| Exercise | Common Stock | 17,566 | $18.01 | $316K |
| Sale | Common Stock | 17,566 | $75.00 | $1.32M |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct, null);
Common Stock — 73,411 shares (Direct, null)
Footnotes (1)
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026. Currently exercisable.
Key Figures
Shares sold: 21,277 shares
Sale price: $75.00 per share
Options exercised: 17,566 shares
+3 more
6 metrics
Shares sold
21,277 shares
Common Stock sold on June 10, 2026 at $75.00
Sale price
$75.00 per share
Open-market sales of Common Stock on June 10, 2026
Options exercised
17,566 shares
Stock options exercised into Common Stock on June 10, 2026
Option exercise price
$18.01 per share
Exercise price of stock option (Right to Buy)
Shares held after transactions
73,411 shares
Direct Common Stock ownership following June 10, 2026 trades
Net share change
38,843 shares disposed
Net-sell direction per transaction summary
Key Terms
Rule 10b5-1 plan, open-market sale, Stock Option (Right to Buy), derivative security, +1 more
5 terms
Rule 10b5-1 plan regulatory
"This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
open-market sale financial
"transaction_action: open-market sale; transaction_code_description: Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transaction did PTCT executive Eric Pauwels report?
Eric Pauwels reported option exercises and share sales in PTC Therapeutics stock. On June 10, 2026, he exercised options for 17,566 shares at $18.01, then sold 21,277 shares at $75.00 in open-market trades under a pre-arranged Rule 10b5-1 plan.
What stock options did Eric Pauwels exercise in PTC Therapeutics (PTCT)?
Eric Pauwels exercised stock options covering 17,566 shares of PTC Therapeutics Common Stock. The options carried an exercise price of $18.01 per share and were described as currently exercisable, with the related option position reduced to zero after this transaction.
What does the derivative transaction in Eric Pauwels’ PTCT Form 4 represent?
The derivative transaction represents a stock option linked to 17,566 underlying PTCT shares with an $18.01 exercise price. On June 10, 2026, Pauwels exercised this currently exercisable option, leaving zero remaining derivative shares outstanding tied to that particular award.